These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33566157)

  • 1. Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants.
    Goeral K; Hauck A; Atkinson A; Wagner MB; Pimpel B; Fuiko R; Klebermass-Schrehof K; Leppert D; Kuhle J; Berger A; Olischar M; Wellmann S
    J Neurol; 2021 Jul; 268(7):2570-2577. PubMed ID: 33566157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants.
    Sjöbom U; Hellström W; Löfqvist C; Nilsson AK; Holmström G; Pupp IH; Ley D; Blennow K; Zetterberg H; Sävman K; Hellström A
    JAMA Netw Open; 2021 Apr; 4(4):e214138. PubMed ID: 33797551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchopulmonary dysplasia is not related to neurofilament light for neuroaxonal damage in preterm infants.
    Romijn M; Baas EM; Lissenberg-Witte BI; Onland W; Königs M; Oosterlaan J; Heijst H; Rotteveel J; van Kaam AH; Teunissen CE; Finken MJJ
    Pediatr Res; 2023 Jun; 93(7):2014-2018. PubMed ID: 36344694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
    McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
    J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases.
    Geis T; Gutzeit S; Fouzas S; Ambrosch A; Benkert P; Kuhle J; Wellmann S
    Eur J Paediatr Neurol; 2023 Jul; 45():9-13. PubMed ID: 37236127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
    Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
    Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
    Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
    Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of serum neurofilament light in the assessment of neurologic outcome in the pediatric population: a systematic literature review.
    Jacobs Sariyar A; van Pesch V; Nassogne MC; Moniotte S; Momeni M
    Eur J Pediatr; 2023 May; 182(5):1941-1948. PubMed ID: 36602623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
    Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
    Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
    Wong YYM; Bruijstens AL; Barro C; Michalak Z; Melief MJ; Wierenga AF; van Pelt ED; Neuteboom RF; Kuhle J; Hintzen RQ
    Neurology; 2019 Sep; 93(10):e968-e974. PubMed ID: 31383792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years.
    Friedova L; Motyl J; Srpova B; Oechtering J; Barro C; Vodehnalova K; Andelova M; Noskova L; Fialová L; Havrdova EK; Horakova D; Benedict RH; Kuhle J; Uher T
    Mult Scler Relat Disord; 2020 Nov; 46():102534. PubMed ID: 33032055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis.
    Chekrouni N; van Soest TM; Brouwer MC; Willemse EAJ; Teunissen CE; van de Beek D
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34903639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.
    Bjornevik K; Munger KL; Cortese M; Barro C; Healy BC; Niebuhr DW; Scher AI; Kuhle J; Ascherio A
    JAMA Neurol; 2020 Jan; 77(1):58-64. PubMed ID: 31515562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
    Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
    Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury.
    Depoorter A; Neumann RP; Barro C; Fisch U; Weber P; Kuhle J; Wellmann S
    Front Neurol; 2018; 9():984. PubMed ID: 30524361
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity.
    Limbrick DD; Morales DM; Shannon CN; Wellons JC; Kulkarni AV; Alvey JS; Reeder RW; Freimann V; Holubkov R; Riva-Cambrin JK; Whitehead WE; Rozzelle CJ; Tamber M; Oakes WJ; Drake JM; Pollack IF; Naftel RP; Inder TE; Kestle JR;
    PLoS One; 2021; 16(3):e0247749. PubMed ID: 33690655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs.
    Yun T; Koo Y; Chae Y; Lee D; Kim H; Kim S; Chang D; Na KJ; Yang MP; Kang BT
    J Vet Intern Med; 2021 Jul; 35(4):1865-1872. PubMed ID: 34114244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.